YOLFTbeta
60

Zhejiang Shouxiangu Pharm Co

603896 · SHG · Healthcare / Biotechnology

13.50CNY-0.20 (-1.46%)

Price History

Full chart

Market Stats

Previous Close13.70
Open13.75
Day Range13.49 – 13.75
52-Week Range12.62 – 22.97
Volume1.23M
Market Cap2.94B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.05
Dividend Yield0.00%
Beta0.26
50-Day Avg14.78
200-Day Avg17.33

About

Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and traditional Chinese medicines under the Shouxiangu brand name. It is also involved in the wholesale and retail; technology research and development; and real estate business. The company was founded in 1909 and is headquartered in Jinhua, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Zhen-Yu Li
  • Employees1.12K
  • HeadquartersNo. 12, Huanglong Third Road, Jinhua, China, 321200, China
  • Websitehttps://www.sxg1909.com

Leadership

  • Mr. Zhen-Yu LiGM & Director · b. 1991
  • Mr. Jing XuDeputy GM & Director · b. 1985
  • Ms. Guofang LiuDeputy GM & Board Secretary · b. 1976
  • Mr. Biao ZhuFinancial Director · b. 1973
  • Yi ChenAccounting Supervisor
  • Mr. Rong Zhi LinVP & Director · b. 1975
  • Mr. Han Bo WangDeputy General Manager · b. 1977

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue177.75M253.03M301.59M301.91M314.88M369.96M511.45M546.76M636.05M767.14M829.07M784.35M691.68M640.18M
Growth (%)-+42.35%+19.19%+0.11%+4.30%+17.49%+38.24%+6.90%+16.33%+20.61%+8.07%-5.39%-11.81%-7.45%
Cost of Revenue76.38M87.86M82.15M57.47M47.58M50.93M72.06M85.41M105.67M126.37M129.21M135.53M133.35M136.55M
Gross Profit101.37M165.17M219.44M244.45M267.30M319.03M439.39M461.35M530.38M640.76M699.86M648.82M558.34M503.63M
Gross Margin57.03%65.28%72.76%80.97%84.89%86.23%85.91%84.38%83.39%83.53%84.42%82.72%80.72%78.67%
Operating Expense68.96M112.52M152.99M186.95M196.32M228.20M329.08M333.58M371.48M433.61M418.99M394.10M383.07M379.73M
Operating Income32.41M52.65M66.45M57.50M70.99M90.84M110.30M127.77M158.90M207.15M280.88M254.72M175.26M123.90M
Operating Margin18.23%20.81%22.03%19.04%22.54%24.55%21.57%23.37%24.98%27.00%33.88%32.48%25.34%19.35%
EBITDA37.79M58.22M92.80M106.17M127.59M127.32M149.86M167.01M209.02M260.69M348.69M346.49M254.26M219.27M
EBITDA Margin21.26%23.01%30.77%35.17%40.52%34.41%29.30%30.55%32.86%33.98%42.06%44.18%36.76%34.25%
Net Income34.02M54.05M69.25M62.64M80.98M88.88M107.65M123.90M151.71M200.83M277.78M254.48M174.71M18.17M
Net Income Margin19.14%21.36%22.96%20.75%25.72%24.02%21.05%22.66%23.85%26.18%33.51%32.44%25.26%2.84%
R&D9.00M12.70M20.55M17.95M17.81M20.97M33.67M39.42M48.49M50.82M47.82M49.68M48.41M51.64M
R&D as % of Total Revenue5.06%5.02%6.81%5.94%5.66%5.67%6.58%7.21%7.62%6.63%5.77%6.33%7.00%8.07%
Interest Expense1.63M1.78M2.48M8.18M7.59M1.91M969.11K978.99K11.99M10.45M13.40M25.05M15.07M24.21M
Interest Expense % of Total Revenue0.92%0.70%0.82%2.71%2.41%0.52%0.19%0.18%1.88%1.36%1.62%3.19%2.18%3.78%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets274.01M409.35M500.99M605.91M612.10M926.34M1.19B1.34B1.70B1.96B2.86B3.17B3.13B3.28B
Total Liabilities135.64M109.85M180.43M237.38M175.17M56.60M206.79M168.31M373.28M342.41M950.67M1.00B837.17M1.02B
Total Equity138.37M299.50M320.56M368.53M436.93M869.75M984.74M1.17B1.33B1.62B1.91B2.17B2.29B2.26B
Cash48.16M77.13M40.90M18.24M4.68M89.19M166.02M205.62M669.25M677.98M1.52B1.50B853.64M778.39M
Total Debt50.00M54.50M104.00M167.60M123.00M-40.00M10.00M188.13M106.56M706.41M736.32M571.17M-
Net Debt1.84M-22.63M63.10M149.36M118.32M-89.19M-126.02M-195.62M-481.12M-571.42M-818.31M-755.56M-282.47M-

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow45.36M65.85M102.90M85.03M95.52M110.80M171.51M207.92M256.36M296.70M341.28M315.06M213.44M228.07M
Investing Cash Flow-32.34M-114.87M-140.93M-145.29M-44.97M-245.16M-249.03M-53.90M89.65M-233.72M-85.39M-1.30B-239.76M-
Financing Cash Flow1.96M78.00M1.80M37.60M-64.10M218.87M96.35M-56.42M117.62M-54.24M335.84M290.08M-243.38M-
Capital Expenditure48.30M113.47M136.17M130.87M40.25M31.45M232.84M91.49M64.98M161.63M182.60M414.54M507.06M273.22M
Free Cash Flow-2.94M-47.62M-33.27M-45.84M55.27M79.36M-61.33M116.43M191.38M135.07M158.68M-99.48M-293.62M-45.15M
Dividends Paid33.65M33.41M47.88M26.00M19.50M18.85M28.97M33.07M49.37M45.89M60.32M92.78M83.00M59.50M
FCF to OCF-6.49%-72.32%-32.33%-53.92%57.86%71.62%-35.76%56.00%74.65%45.53%46.50%-31.58%-137.56%-19.79%
Dividend Paid to FCF-1142.47%-70.16%-143.91%-56.71%35.29%23.75%-47.24%28.40%25.80%33.97%38.01%-93.26%-28.27%-131.79%

Earnings

Report DateJun 30, 2017Oct 26, 2017Dec 31, 2017Apr 26, 2018Jul 24, 2018Oct 25, 2018Jan 30, 2019Apr 25, 2019Aug 27, 2019Oct 29, 2019Feb 18, 2020Apr 27, 2020Aug 24, 2020Oct 27, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Mar 31, 2022Apr 27, 2022Jul 21, 2022Oct 26, 2022Mar 3, 2023Apr 27, 2023
EPS Estimate------------------------
EPS Actual0.090.050.210.200.100.030.260.240.020.060.510.230.050.140.460.450.070.170.590.270.130.250.770.33
Surprise------------------------
Timing-After-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hours-Pre-market--After-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap2.94B
Enterprise Value2.53B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.77
Price / Book1.27
EPS-0.05
Book Value11.54
Revenue (TTM)616.54M
Gross Profit (TTM)473.43M
EBITDA164.43M
Profit Margin-1.71%
Operating Margin3.23%
Return on Equity-0.47%
Return on Assets1.71%
Shares Outstanding198.24M
Shares Float111.94M
Beta0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.44Jul 4, 2023
20221×
0.41May 26, 2022
20211×
0.24Jun 30, 2021
20201×
0.27May 26, 2020
20191×
0.18Jun 18, 2019
20181×
0.15Jul 12, 2018

Stock Splits

  • May 26, 202213:10